-
1
-
-
0024551135
-
Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients
-
Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243.
-
(1989)
J Urol
, vol.141
, pp. 243
-
-
Mebust, W.K.1
Holtgrewe, H.L.2
Cockett, A.T.K.3
Peters, P.C.4
-
2
-
-
0029939081
-
The Hytrin Community Assessment Trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia
-
Roehrborn CG, Oesterling JE, Auerbach S et al. The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. Urology 1996; 47: 159-68
-
(1996)
Urology
, vol.47
, pp. 159-168
-
-
Roehrborn, C.G.1
Oesterling, J.E.2
Auerbach, S.3
-
3
-
-
0030248565
-
Safety and efficacy of doxazosin in benign prostatic hyperplasia: Apooled analysis of three double-blind, placebo-controlled studies
-
Roehrborn CG, Siegel RL. Safety and efficacy of doxazosin in benign prostatic hyperplasia: apooled analysis of three double-blind, placebo-controlled studies. Urology 1996; 48: 406-15
-
(1996)
Urology
, vol.48
, pp. 406-415
-
-
Roehrborn, C.G.1
Siegel, R.L.2
-
4
-
-
0029034556
-
Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia
-
Kawabe K. Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia. Br J Urol 1995; 76: 63-7
-
(1995)
Br J Urol
, vol.76
, pp. 63-67
-
-
Kawabe, K.1
-
5
-
-
0035667615
-
Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: A randomized, placebo-controlled trial
-
Roehrborn CG. Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial. Urology 2001; 58: 953-9
-
(2001)
Urology
, vol.58
, pp. 953-959
-
-
Roehrborn, C.G.1
-
6
-
-
9444268678
-
The efficacy of terazosin, finasteride or both in benign prostatic hyperplasia
-
Lepor H, Williford WO, Barry MJ et al. The efficacy of terazosin, finasteride or both in benign prostatic hyperplasia. N Engl J Med 1996; 335: 533-9
-
(1996)
N Engl J Med
, vol.335
, pp. 533-539
-
-
Lepor, H.1
Williford, W.O.2
Barry, M.J.3
-
7
-
-
0037253614
-
Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: The Prospective European Doxazosin and Combination Therapy (PREDICT) trial
-
Kirby RS, Roehrborn C, Boyle P et al. Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial. Urology2003; 61: 119-26
-
(2003)
Urology
, vol.61
, pp. 119-126
-
-
Kirby, R.S.1
Roehrborn, C.2
Boyle, P.3
-
8
-
-
0347882750
-
The long-term effect of doxazosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia
-
McConnell JD, Roehrborn CG, Bautista OM et al. The long-term effect of doxazosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387-98
-
(2003)
N Engl J Med
, vol.349
, pp. 2387-2398
-
-
McConnell, J.D.1
Roehrborn, C.G.2
Bautista, O.M.3
-
9
-
-
0036754256
-
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
-
Roehrborn CG, Boyle P, Nickel JC et al. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology, 2002; 60: 434-41
-
(2002)
Urology
, vol.60
, pp. 434-441
-
-
Roehrborn, C.G.1
Boyle, P.2
Nickel, J.C.3
-
10
-
-
0342618512
-
Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia
-
Andersen JT, Nickel JC, Marshall VR et al. Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. Urology 1997; 49: 839-45
-
(1997)
Urology
, vol.49
, pp. 839-845
-
-
Andersen, J.T.1
Nickel, J.C.2
Marshall, V.R.3
-
11
-
-
0029024794
-
The Agency for Healthcare Policy and Research. Clinical Guidelines for the diagnosis and treatment of benign prostatic hyperplasia
-
Roehrborn CG. The Agency for Healthcare Policy and Research. Clinical Guidelines for the diagnosis and treatment of benign prostatic hyperplasia. Urol Clin North Am 1995; 22: 445-53
-
(1995)
Urol Clin North Am
, vol.22
, pp. 445-453
-
-
Roehrborn, C.G.1
-
12
-
-
2542642296
-
Guideline for the primary care management of male lower urinary tract symptoms
-
in press
-
Speakman MJ, Kirby RS, Joyce A et al. Guideline for the primary care management of male lower urinary tract symptoms. BJU Int 2004; 93: in press
-
(2004)
BJU Int
, vol.93
-
-
Speakman, M.J.1
Kirby, R.S.2
Joyce, A.3
|